Who Paid My Doc
Lee Trotter
Pediatric Surgery Orem, UT Doctor of Osteopathy
NPI 1013986157 CMS profile 227761
750 W 800 N Ste 330, Orem, UT 84057
General payments
$4,223
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Lee Trotter of Orem, UT is reported in the CMS Open Payments database as having received $4,223 across 42 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 86th percentile of Pediatric Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $49 | 2 | |
| 2024 | General | $323 | 10 | |
| 2023 | General | $67 | 3 | |
| 2022 | General | $108 | 3 | |
| 2021 | General | $28 | 2 | |
| 2020 | General | $1,314 | 9 | |
| 2019 | General | $2,335 | 13 |
Beside peers
- Lee Trotter
- Pediatric Surgery median
- Middle half of Pediatric Surgery
- National median
In program year 2025, general payments to Lee Trotter were reported at $49. Among 513 Pediatric Surgery profiles paid that year, the median was $136 and the middle half received between $40 and $362.
Show as a table
| Year | Lee Trotter | Pediatric Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $2,335 | $79 | $25–$162 | $163 |
| 2020 | $1,314 | $48 | $15–$174 | $114 |
| 2021 | $28 | $82 | $26–$444 | $132 |
| 2022 | $108 | $101 | $31–$246 | $149 |
| 2023 | $67 | $88 | $31–$277 | $160 |
| 2024 | $323 | $110 | $42–$386 | $164 |
| 2025 | $49 | $136 | $40–$362 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 44 billing codesPaid by Medicare
$16,386
Medicare patients
50
Services billed
110
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 72% | |
| Arthritis | 62% | |
| Depression | 58% | |
| Chronic kidney disease | 42% | |
| Diabetes | 40% | |
| Heart failure | 34% | |
| Atrial fibrillation | 34% | |
| Ischemic heart disease | 28% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
42 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Pediatric Surgery in Utah
Sarah Ogle
Pediatric Surgery · Orem, UT
David Skarda
Pediatric Surgery · Salt Lake City, UT
Scott Short
Pediatric Surgery · Salt Lake City, UT
Michael Rollins
Pediatric Surgery · Salt Lake City, UT
Jay Riva-Cambrin
Pediatric Surgery · Salt Lake City, UT
Robert Swendiman
Pediatric Surgery · Salt Lake City, UT
Related records
Pediatric Surgery in Utah
Practitioners in the same specialty and state, ranked by reported value.
All Pediatric Surgery
Everyone recorded under this specialty, nationwide.
Doctors in Utah
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.